cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.15468/dl.frretj
title: Occurrence Download

description: A dataset containing 85 species occurrences available in GBIF matching the query:
{
 "and" : [
 "TaxonKey is one of (Rineloricaria kronei)",
 "BasisOfRecord is one of (Specimen, Literature Occurrence, Human Observation, Observation)",
 "HasCoordinate is true",
 "HasGeospatialIssue is false",
 "Year is greater than or equal to 1991",
 "Year is less than or equal to 2025"
 ]
}

 The dataset includes 85 records from 8 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0049632-250717081556266/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.yj7tee
title: Occurrence Download

description: A dataset containing 657 species occurrences available in GBIF matching the query:
{
 "and" : [
 "TaxonKey is Pisum sativum",
 "Country is Belgium",
 "HasCoordinate is true"
 ]
}

 The dataset includes 657 records from 14 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0049635-250717081556266/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.z5vvz8
title: Occurrence Download

description: A dataset containing 722 species occurrences available in GBIF matching the query:
{
 "TaxonKey" : [
 "is Howella sherborni"
 ]
}

 The dataset includes 722 records from 49 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0049633-250717081556266/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.wg3cwm
title: Occurrence Download

description: A dataset containing 54071 species occurrences available in GBIF matching the query:
{
 "and" : [
 "TaxonKey is one of (Calidris subminuta)",
 "HasCoordinate is true",
 "OccurrenceStatus is Present",
 "License is one of (CC-BY 4.0, CC0 1.0)"
 ]
}

 The dataset includes 54071 records from 61 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0049610-250717081556266/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.jwgx3e
title: Occurrence Download

description: A dataset containing 1 species occurrences available in GBIF matching the query:
{
 "and" : [
 "TaxonKey is Thunbergia grandiflora",
 "Country is Fiji",
 "HasCoordinate is true"
 ]
}

 The dataset includes 1 records from 1 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0049636-250717081556266/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.3y2js5
title: Occurrence Download

description: A dataset containing 84712 species occurrences available in GBIF matching the query:
{
 "and" : [
 "TaxonKey is one of (Calidris subruficollis)",
 "HasCoordinate is true",
 "OccurrenceStatus is Present",
 "License is one of (CC-BY 4.0, CC0 1.0)"
 ]
}

 The dataset includes 84712 records from 142 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0049613-250717081556266/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.adrjtk
title: Occurrence Download

description: A dataset containing 16375 species occurrences available in GBIF matching the query:
{
 "and" : [
 "HasCoordinate is true",
 "TaxonKey is Sigesbeckia orientalis"
 ]
}

 The dataset includes 16375 records from 226 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0049634-250717081556266/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.8646v7
title: Occurrence Download

description: A dataset containing 190635 species occurrences available in GBIF matching the query:
{
 "and" : [
 "TaxonKey is one of (Calidris ruficollis)",
 "HasCoordinate is true",
 "OccurrenceStatus is Present",
 "License is one of (CC-BY 4.0, CC0 1.0)"
 ]
}

 The dataset includes 190635 records from 110 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0049609-250717081556266/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.34740/kaggle/dsv/12581541
title: World Weather Repository ( Daily Updating )
DOI: 10.15468/dl.uqkfgb
title: Occurrence Download

description: A dataset containing 4 species occurrences available in GBIF matching the query:
{
 "and" : [
 "TaxonKey is Pisum sativum",
 "Country is Bosnia and Herzegovina",
 "HasCoordinate is true"
 ]
}

 The dataset includes 4 records from 1 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0049637-250717081556266/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.jswjsx
title: Occurrence Download

description: A dataset containing 23 species occurrences available in GBIF matching the query:
{
 "and" : [
 "TaxonKey is one of (Astyanax hamatilis)",
 "BasisOfRecord is one of (Specimen, Literature Occurrence, Human Observation, Observation)",
 "HasCoordinate is true",
 "HasGeospatialIssue is false",
 "Year is greater than or equal to 1991",
 "Year is less than or equal to 2025"
 ]
}

 The dataset includes 23 records from 4 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0049638-250717081556266/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.d8skf9
title: Occurrence Download

description: A dataset containing 267 species occurrences available in GBIF matching the query:
{
 "TaxonKey" : [
 "is Hydrolagus affinis"
 ]
}

 The dataset includes 267 records from 35 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0049640-250717081556266/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.9kxw79
title: Occurrence Download

description: A dataset containing 31 species occurrences available in GBIF matching the query:
{
 "and" : [
 "TaxonKey is Pisum sativum",
 "Country is Bulgaria",
 "HasCoordinate is true"
 ]
}

 The dataset includes 31 records from 9 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0049644-250717081556266/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.hehvrp
title: Occurrence Download

description: A dataset containing 1375 species occurrences available in GBIF matching the query:
{
 "and" : [
 "Geometry POLYGON((6.26193 42.82725,16.64003 42.82725,16.64003 46.97671,6.26193 46.97671,6.26193 42.82725))",
 "HasCoordinate is true",
 "HasGeospatialIssue is false",
 "OccurrenceStatus is Present",
 "TaxonKey is Leucos aula"
 ]
}

 The dataset includes 1375 records from 17 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0049641-250717081556266/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.gbvs6t
title: Occurrence Download

description: A dataset containing 60 species occurrences available in GBIF matching the query:
{
 "and" : [
 "TaxonKey is Pisum sativum",
 "Country is Canada",
 "HasCoordinate is true"
 ]
}

 The dataset includes 60 records from 12 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0049645-250717081556266/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.6084/m9.figshare.29290233
title: A multimodal intervention of manual therapy, exercise, and psychological management for painful diabetic neuropathy: intervention development and feasibility trial protocol

description: Therapeutic options for people experiencing neuropathic pain from diabetic peripheral neuropathy are limited, and impact can be severe. Physical and psychological interventions remain under-explored but may offer promise, especially in multimodal combination programs. To address this gap, an intervention was developed according to the Medical Research Council’s framework for complex interventions, including research expert and stakeholder input. This will be tested for acceptability and feasibility in a trial. NeuOst (Neuropathy Optimisation through Self-management and Therapy) is a manual therapy-based intervention, incorporating exercise, psychologically informed training, and education. The protocol for a single-site, parallel, three-arm, partially participant-blinded, randomized controlled trial is presented. The experimental treatment is a 5-week course of NeuOst as adjunct to patients’ usual care. Comparators are a control intervention that lacks pre-specified components of interest as adjunct to usual care and usual care only in adults with painful diabetic peripheral neuropathy. The follow-up period is 16 weeks. Primary outcomes are feasibility measures such as recruitment, eligibility, and consent rates, retention, blinding, fidelity, acceptability, and safety. Secondary and exploratory outcomes involve clinical measures and qualitative feedback. A protocol was prospectively registered (NCT06423391). After initial intervention development, a feasibility trial will inform intervention refinement and future research steps. www.clinicaltrials.gov identifier is NCT06423391. People with diabetes can develop nerve pain in their feet, which can greatly affect quality of life. Current treatments are limited. Physical and psychological approaches – like exercise, massage, and supportive conversations – may help but are rarely combined or fully tested. We have developed a new treatment program called NeuOst, which brings together hands-on therapy, exercise, and conversations for pain management. It was designed with people with lived experience, healthcare professionals, and researchers. We are now running a small study to test whether this program is practical to deliver and acceptable to participants. Adults with painful diabetic neuropathy are randomly placed into one of three groups (in addition to their normal care outside the study):
NeuOst (5 sessions)A comparison treatment (similar to NeuOst but with some elements removed; 5 sessions)Usual care only NeuOst (5 sessions) A comparison treatment (similar to NeuOst but with some elements removed; 5 sessions) Usual care only We follow participants for 16 weeks and look at how the program was delivered, how people experienced it, and any early signs of benefit. The results will guide improvements to the treatment and inform future research.
DOI: 10.6084/m9.figshare.29290233.v1
title: A multimodal intervention of manual therapy, exercise, and psychological management for painful diabetic neuropathy: intervention development and feasibility trial protocol

description: Therapeutic options for people experiencing neuropathic pain from diabetic peripheral neuropathy are limited, and impact can be severe. Physical and psychological interventions remain under-explored but may offer promise, especially in multimodal combination programs. To address this gap, an intervention was developed according to the Medical Research Council’s framework for complex interventions, including research expert and stakeholder input. This will be tested for acceptability and feasibility in a trial. NeuOst (Neuropathy Optimisation through Self-management and Therapy) is a manual therapy-based intervention, incorporating exercise, psychologically informed training, and education. The protocol for a single-site, parallel, three-arm, partially participant-blinded, randomized controlled trial is presented. The experimental treatment is a 5-week course of NeuOst as adjunct to patients’ usual care. Comparators are a control intervention that lacks pre-specified components of interest as adjunct to usual care and usual care only in adults with painful diabetic peripheral neuropathy. The follow-up period is 16 weeks. Primary outcomes are feasibility measures such as recruitment, eligibility, and consent rates, retention, blinding, fidelity, acceptability, and safety. Secondary and exploratory outcomes involve clinical measures and qualitative feedback. A protocol was prospectively registered (NCT06423391). After initial intervention development, a feasibility trial will inform intervention refinement and future research steps. www.clinicaltrials.gov identifier is NCT06423391. People with diabetes can develop nerve pain in their feet, which can greatly affect quality of life. Current treatments are limited. Physical and psychological approaches – like exercise, massage, and supportive conversations – may help but are rarely combined or fully tested. We have developed a new treatment program called NeuOst, which brings together hands-on therapy, exercise, and conversations for pain management. It was designed with people with lived experience, healthcare professionals, and researchers. We are now running a small study to test whether this program is practical to deliver and acceptable to participants. Adults with painful diabetic neuropathy are randomly placed into one of three groups (in addition to their normal care outside the study):
NeuOst (5 sessions)A comparison treatment (similar to NeuOst but with some elements removed; 5 sessions)Usual care only NeuOst (5 sessions) A comparison treatment (similar to NeuOst but with some elements removed; 5 sessions) Usual care only We follow participants for 16 weeks and look at how the program was delivered, how people experienced it, and any early signs of benefit. The results will guide improvements to the treatment and inform future research.
DOI: 10.6084/m9.figshare.29366177
title: Effectiveness of conditioning + open-label placebo for post-operative pain management in adolescent idiopathic scoliosis

description: The vast majority of placebos are administered with concealment or deception. Most clinicians and researchers believe that either deception or concealment is necessary to achieve a placebo response; however, recent studies with open-label placebo (OLP), conditioning, and conditioning + OLP (COLP) have shown that placebos can be effective even when patients know they are receiving a placebo. To date, no studies have examined COLP in a pediatric surgical population, which is vulnerable to developing opioid dependence. COLP may assist in lowering opioid doses administered and quicker tapering off opioids. This study investigates the effectiveness of COLP on postoperative treatment of patients ages 10 through 17 undergoing posterior fusion for adolescent idiopathic scoliosis (AIS). It is a randomized controlled trial of 64 AIS patients assigned to one of the two arms: COLP + treatment as usual (TAU) and TAU control. Randomization and baseline assessments occur at the preoperative visit. Opioid consumption is recorded weekly after hospitalization until the first in-person postoperative visit at 6 weeks. The primary outcome measure is postoperative opioid consumption, both amount and duration. Secondary outcomes include pain, functional ability, and mental health scores. A placebo is an inactive substance, such as a sugar pill. Historical use of placebos involves concealment in randomized controlled trials, such that patients do not know if they are receiving a placebo or an active medication. Recent research studies have shown that open-label placebos, meaning sugar pills that patients know are sugar pills, are able to help reduce pain and help relieve other uncomfortable symptoms. Other research has shown that pairing opioids with inert pills can cause inert pills to relieve pain. Our ongoing study pairs the effects of open-label placebos with conditioning. We hope to reduce overall opioid use. We are specifically looking at opioid use in the 6-week period after spinal surgery in patients aged 10 to 17 who are having surgery for a condition called adolescent idiopathic scoliosis. Scoliosis refers to an abnormal curvature of the spine, and idiopathic means that we are not sure of the exact cause of this curvature. If we find that placebos reduce opioid use, this research could help future children who undergo spine surgery and other painful surgeries take less opioids and have less pain. www.clinicaltrials.gov identifier is NCT06365892.
DOI: 10.6084/m9.figshare.29366177.v1
title: Effectiveness of conditioning + open-label placebo for post-operative pain management in adolescent idiopathic scoliosis

description: The vast majority of placebos are administered with concealment or deception. Most clinicians and researchers believe that either deception or concealment is necessary to achieve a placebo response; however, recent studies with open-label placebo (OLP), conditioning, and conditioning + OLP (COLP) have shown that placebos can be effective even when patients know they are receiving a placebo. To date, no studies have examined COLP in a pediatric surgical population, which is vulnerable to developing opioid dependence. COLP may assist in lowering opioid doses administered and quicker tapering off opioids. This study investigates the effectiveness of COLP on postoperative treatment of patients ages 10 through 17 undergoing posterior fusion for adolescent idiopathic scoliosis (AIS). It is a randomized controlled trial of 64 AIS patients assigned to one of the two arms: COLP + treatment as usual (TAU) and TAU control. Randomization and baseline assessments occur at the preoperative visit. Opioid consumption is recorded weekly after hospitalization until the first in-person postoperative visit at 6 weeks. The primary outcome measure is postoperative opioid consumption, both amount and duration. Secondary outcomes include pain, functional ability, and mental health scores. A placebo is an inactive substance, such as a sugar pill. Historical use of placebos involves concealment in randomized controlled trials, such that patients do not know if they are receiving a placebo or an active medication. Recent research studies have shown that open-label placebos, meaning sugar pills that patients know are sugar pills, are able to help reduce pain and help relieve other uncomfortable symptoms. Other research has shown that pairing opioids with inert pills can cause inert pills to relieve pain. Our ongoing study pairs the effects of open-label placebos with conditioning. We hope to reduce overall opioid use. We are specifically looking at opioid use in the 6-week period after spinal surgery in patients aged 10 to 17 who are having surgery for a condition called adolescent idiopathic scoliosis. Scoliosis refers to an abnormal curvature of the spine, and idiopathic means that we are not sure of the exact cause of this curvature. If we find that placebos reduce opioid use, this research could help future children who undergo spine surgery and other painful surgeries take less opioids and have less pain. www.clinicaltrials.gov identifier is NCT06365892.
DOI: 10.6084/m9.figshare.29290059
title: Efficacy of intra-articular opioid injections for managing temporomandibular joint nociception: a systematic review

description: This systematic review evaluated randomized controlled trials (RCTs) investigating the effectiveness of intra-articular opioid injections for managing temporomandibular joint (TMJ) pain. A comprehensive search of indexed databases and Google Scholar was conducted following PRISMA guidelines. Included studies assessed self-reported TMJ pain and maximum mouth opening (MMO) as primary and secondary outcomes, respectively. Risk of bias (RoB) was evaluated using the Cochrane tool, and evidence certainty was rated using the GRADE framework. Ten RCTs met the inclusion criteria, with follow-up periods ranging from 30 minutes to 6 months. Six trials demonstrated significant pain reduction after opioid injections, while one reported no difference following morphine use. Another study found mepivacaine more effective than morphine or saline. Regarding MMO, one trial showed no effect of morphine, whereas two trials found that 1 mg morphine or 1 ml buprenorphine led to greater improvements than 0.1 mg morphine. In three trials, opioids enhanced MMO more than sodium hyaluronate. All studies exhibited low RoB. Certainty of evidence was moderate in six RCTs and low in three. There is no credible evidence for the benefit of intra-articular opioid-injections for managing TMJ nociception. www.crd.tork.ac.uk/prospero identified is CRD42024598035. <b>What We Did:</b> We wanted to find out if injecting opioids into the jaw joint (JJ) helps reduce pain in people with jaw joint problems. <b>How We Did It:</b> We examined multiple scientific databases for interventional studies that tested the effectiveness of opioid injections for pain in the JJ. We only included studies done in humans and included a group in which, sham treatment was done. We also assessed the quality of the studies and analyzed their findings. <b>What We Found:</b> We reviewed 10 studies. Most of them showed that opioid injections helped reduce pain. However, one study found no pain relief when opioids were mixed with numbing medicine. Another study showed that higher doses of opioids helped people open their mouths more easily. The overall quality of the studies was not strong because they used different methods. <b>Conclusions:</b> Opioid injections seem to help with JJ pain, but differences in study methods make it hard to be sure. More high-quality research is needed to confirm how well opioid injections work for JJ pain.